378 related articles for article (PubMed ID: 31009605)
1. Knockout of adenylyl cyclase isoform 5 or 6 differentially modifies the β
Cosson MV; Hiis HG; Moltzau LR; Levy FO; Krobert KA
J Mol Cell Cardiol; 2019 Jun; 131():132-145. PubMed ID: 31009605
[TBL] [Abstract][Full Text] [Related]
2. Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6.
Bull Melsom C; Cosson MV; Ørstavik Ø; Lai NC; Hammond HK; Osnes JB; Skomedal T; Nikolaev V; Levy FO; Krobert KA
PLoS One; 2019; 14(6):e0218110. PubMed ID: 31173603
[TBL] [Abstract][Full Text] [Related]
3. Gi proteins regulate adenylyl cyclase activity independent of receptor activation.
Melsom CB; Ørstavik Ø; Osnes JB; Skomedal T; Levy FO; Krobert KA
PLoS One; 2014; 9(9):e106608. PubMed ID: 25203113
[TBL] [Abstract][Full Text] [Related]
4. Non-classical regulation of β1- and β 2-adrenoceptor-mediated inotropic responses in rat heart ventricle by the G protein Gi.
Melsom CB; Hussain RI; Ørstavik Ø; Aronsen JM; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Krobert KA
Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1177-86. PubMed ID: 25216690
[TBL] [Abstract][Full Text] [Related]
5. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes.
Xiao RP; Avdonin P; Zhou YY; Cheng H; Akhter SA; Eschenhagen T; Lefkowitz RJ; Koch WJ; Lakatta EG
Circ Res; 1999 Jan 8-22; 84(1):43-52. PubMed ID: 9915773
[TBL] [Abstract][Full Text] [Related]
6. The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.
Hussain RI; Aronsen JM; Afzal F; Sjaastad I; Osnes JB; Skomedal T; Levy FO; Krobert KA
J Mol Cell Cardiol; 2013 Mar; 56():129-38. PubMed ID: 23220156
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP-dependent inotropic effects are differentially regulated by muscarinic G(i)-dependent constitutive inhibition of adenylyl cyclase in failing rat ventricle.
Hussain RI; Afzal F; Mørk HK; Aronsen JM; Sjaastad I; Osnes JB; Skomedal T; Levy FO; Krobert KA
Br J Pharmacol; 2011 Feb; 162(4):908-16. PubMed ID: 21039419
[TBL] [Abstract][Full Text] [Related]
8. Coupling of β1-adrenergic receptor to type 5 adenylyl cyclase and its physiological relevance in cardiac myocytes.
Tsunematsu T; Okumura S; Mototani Y; Ohnuki Y; Jin H; Cai W; Suita K; Sato I; Umemura M; Yokoyama U; Sato M; Fujita T; Ishikawa Y
Biochem Biophys Res Commun; 2015 Mar; 458(3):531-535. PubMed ID: 25677623
[TBL] [Abstract][Full Text] [Related]
9. A long lasting β1 adrenergic receptor stimulation of cAMP/protein kinase A (PKA) signal in cardiac myocytes.
Fu Q; Kim S; Soto D; De Arcangelis V; DiPilato L; Liu S; Xu B; Shi Q; Zhang J; Xiang YK
J Biol Chem; 2014 May; 289(21):14771-81. PubMed ID: 24713698
[TBL] [Abstract][Full Text] [Related]
10. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
Galindo-Tovar A; Kaumann AJ
Br J Pharmacol; 2008 Feb; 153(4):710-20. PubMed ID: 18084319
[TBL] [Abstract][Full Text] [Related]
12. Agonist-independent tonic inhibitory influence of Gi on adenylate cyclase activity in rabbit ventricular myocardium and its removal by pertussis toxin: a role of empty receptor-mediated Gi activation.
Akaishi Y; Hattori Y; Kanno M; Sakuma I; Kitabatake A
J Mol Cell Cardiol; 1997 Feb; 29(2):765-75. PubMed ID: 9140833
[TBL] [Abstract][Full Text] [Related]
13. Heterologous desensitization of cardiac β-adrenergic signal via hormone-induced βAR/arrestin/PDE4 complexes.
Shi Q; Li M; Mika D; Fu Q; Kim S; Phan J; Shen A; Vandecasteele G; Xiang YK
Cardiovasc Res; 2017 May; 113(6):656-670. PubMed ID: 28339772
[TBL] [Abstract][Full Text] [Related]
14. PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.
Molenaar P; Christ T; Hussain RI; Engel A; Berk E; Gillette KT; Chen L; Galindo-Tovar A; Krobert KA; Ravens U; Levy FO; Kaumann AJ
Br J Pharmacol; 2013 Jun; 169(3):528-38. PubMed ID: 23489141
[TBL] [Abstract][Full Text] [Related]
15. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.
Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML
Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical attenuation of β2-AR function in airway smooth muscle by Gi-mediated counterregulation in transgenic mice overexpressing type 5 adenylyl cyclase.
Wang WC; Schillinger RM; Malone MM; Liggett SB
Am J Physiol Lung Cell Mol Physiol; 2011 Mar; 300(3):L472-8. PubMed ID: 21131397
[TBL] [Abstract][Full Text] [Related]
19. β2-adrenergic receptor-coupled phosphoinositide 3-kinase constrains cAMP-dependent increases in cardiac inotropy through phosphodiesterase 4 activation.
Gregg CJ; Steppan J; Gonzalez DR; Champion HC; Phan AC; Nyhan D; Shoukas AA; Hare JM; Barouch LA; Berkowitz DE
Anesth Analg; 2010 Oct; 111(4):870-7. PubMed ID: 20705779
[TBL] [Abstract][Full Text] [Related]
20. Annexin A4 N-terminal peptide inhibits adenylyl cyclase 5 and limits β-adrenoceptor-mediated prolongation of cardiac action potential.
Heinick A; Pluteanu F; Hermes C; Klemme A; Domnik M; Husser X; Gerke V; Schmitz W; Müller FU
FASEB J; 2020 Aug; 34(8):10489-10504. PubMed ID: 32579290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
